Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.40 |
| ▸ | CES1 | P23141 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2767621 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL13990397 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31284893 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31285033 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31285016 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31284710 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31285494 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL31310782 | 0.95 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL3174321 | 0.88 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A | |
| SCHEMBL3175863 | 0.88 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPK1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1824952-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2010-04-28 | — | — | EP | claimed |
| US-20100021413-A1 | Malodor Counteracting Compositions | GIVAUDAN SA (CH) | 2010-01-28 | — | — | US | claimed |
| EP-2086594-A1 | MALODOR COUNTERACTING COMPOSITIONS | Givaudan SA (CH) | 2009-08-12 | — | — | EP | claimed |
| US-20080306170-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | claimed |
| WO-2008055372-A1 | MALODOR COUNTERACTING COMPOSITIONS | GIVAUDAN SA (CH) | 2008-05-15 | — | — | WO | claimed |
| CN-101072857-A | Organic compounds | GIVAUDAN SA (CH) | 2007-11-14 | — | — | CN | claimed |
| EP-4731734-A1 | FRAGRANCE INGREDIENTS | Givaudan SA (CH) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024261137-A1 | FRAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2024-12-26 | — | — | WO | disclosed |
| EP-4481022-A1 | FRAGRANCE INGREDIENTS | Givaudan SA (CH) | 2024-12-25 | — | — | EP | disclosed |
| US-9102899-B2 | Organic compounds | GIVAUDAN SA (CH) | 2015-08-11 | — | — | US | disclosed |
| EP-1824952-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2010-04-28 | — | — | EP | disclosed |
| US-20100021413-A1 | Malodor Counteracting Compositions | GIVAUDAN SA (CH) | 2010-01-28 | — | — | US | disclosed |
| EP-2086594-A1 | MALODOR COUNTERACTING COMPOSITIONS | Givaudan SA (CH) | 2009-08-12 | — | — | EP | disclosed |
| US-20080306170-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | disclosed |
| WO-2008055372-A1 | MALODOR COUNTERACTING COMPOSITIONS | GIVAUDAN SA (CH) | 2008-05-15 | — | — | WO | disclosed |
| CN-101072857-A | Organic compounds | GIVAUDAN SA (CH) | 2007-11-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306170-A1 | Organic Compounds | PNN, TRPA1, PAOX | SMN1; SMN2 899/4885ALDH1A1 257/4885MAPK1 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.